The 5, 10 methylenetetrahydrofolate reductase C677T mutation and risk of fetal loss: a case series and review of the literature
2007

MTHFR C677T Mutation and Fetal Loss

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): Ivy Altomare, Alan Adler, Louis M Aledort

Primary Institution: Mount Sinai Medical Center

Hypothesis

The relationship between methylenetetrahydrofolate reductase C677T homozygosity and risk of recurrent spontaneous abortion is unknown.

Conclusion

The study provides evidence that MTHFR C677T mutations are associated with recurrent fetal loss and that anticoagulation during pregnancy can lead to successful outcomes.

Supporting Evidence

  • Two women had successful full-term deliveries on LMW heparin.
  • One woman is currently pregnant in her third trimester with no complications after receiving LMW heparin.
  • Five patients are trying to conceive after being recommended LMW heparin upon conception.

Takeaway

Some women with a specific gene mutation might have trouble keeping their babies, but giving them a special medicine during pregnancy can help them have healthy babies.

Methodology

The study involved 8 patients who were homozygous for the MTHFR C677T mutation and had histories of spontaneous fetal loss, with treatment involving low-molecular weight heparin.

Limitations

The study is a case series and lacks randomized controlled trials to definitively establish the effectiveness of anticoagulation in these patients.

Participant Demographics

The mean age of participants was 36 years, with a history of 1 to 6 previous miscarriages.

Digital Object Identifier (DOI)

10.1186/1477-9560-5-17

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication